Table 4.
Association between the scores of CDQ and GerdQ and demographic factors among GERD patients (univariate analysis)
| Web-based population |
Mail-survey population |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDQ < 6 (n = 135) | CDQ ≥ 6 (n = 227) | OR (95% CI) | GerdQ< 8 (n = 183) | GerdQ ≥ 8 (n = 179) | OR (95% CI) | CDQ < 6 (n = 40) | CDQ ≥ 6 (n = 87) | OR (95% CI) | GerdQ < 8 (n = 71) | GerdQ ≥ 8 (n = 87) | OR (95% CI) | |
| Age (years) | 40.8 ± 9.2 | 42.6 ± 9.0 | 1.02 (1.00–1.05) | 40.2 ± 9.1 | 43.7 ± 8.8 | 1.05 (1.02–1.07) | 50.3 ± 6.0 | 48.5 ± 9.0 | 0.97 (0.93–1.02) | 49.1 ± 7.9 | 49.0 ± 8.6 | 1.00 (0.96–1.04) |
| Gender (men) | 52 (38.5) | 121 (53.3) | 1.82 (1.18–2.81) | 88 (48.1) | 85 (47.5) | 0.98 (0.65–1.48) | 22 (55.0) | 46 (52.9) | 0.92 (0.43–1.95) | 29 (40.8) | 39 (69.6) | 3.32 (1.58–6.97) |
| Heavy smoking (> 15/day) | 17 (12.6) | 28 (12.3) | 0.98 (0.51–1.86) | 20 (44.4) | 25 (55.6) | 1.32 (0.71–2.48) | 2 (5.0) | 12 (13.8) | 3.04 (0.65–14.3) | 7 (9.9) | 7 (12.5) | 1.31 (0.43–3.97) |
| Heavy alcohol consumption (5–7 days/week) | 28 (20.7) | 67 (29.5) | 1.60 (0.97–2.65) | 46 (25.1) | 49 (27.4) | 1.12 (0.70–1.79) | 6 (15.0) | 14 (16.1) | 1.09 (0.38–3.07) | 11 (15.5) | 9 (16.1) | 1.04 (0.40–2.73) |
| Metabolic syndrome | 49 (36.3) | 109 (48.0) | 1.62 (1.05–2.51) | 68 (37.2) | 90 (50.3) | 1.71 (1.13–2.60) | 20 (50.0) | 35 (40.2) | 0.67 (0.32–1.43) | 24 (33.8) | 31 (55.4) | 2.43 (1.18–4.99) |
| Using both prescription and OTC medications | 8 (5.9) | 26 (11.5) | 2.05 (0.90–4.68) | 6 (3.3) | 28 (15.6) | 5.47 (2.21–13.6) | 4 (10.0) | 7 (8.0) | 0.79 (0.22–2.86) | 3 (4.2) | 8 (14.3) | 3.78 (0.95–15.0) |
Values are mean ± SD or n (%), unless otherwise stated. Bold indicates significant differences.
CDQ, Carlsson-Dent questionnaire; OTC, over-the-counter.